Cargando…

Notoginsenoside R1 for Organs Ischemia/Reperfusion Injury: A Preclinical Systematic Review

Notoginsenoside R1 (NGR1) exerts pharmacological actions for a variety of diseases such as myocardial infarction, ischemic stroke, acute renal injury, and intestinal injury. Here, we conducted a preclinical systematic review of NGR1 for ischemia reperfusion (I/R) injury. Eight databases were searche...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tong, Qiang, Zhu, Peng-chong, Zhuang, Zhuang, Deng, Li-hui, Wang, Zi-hao, Zeng, Hua, Zheng, Guo-qing, Wang, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811647/ https://www.ncbi.nlm.nih.gov/pubmed/31680976 http://dx.doi.org/10.3389/fphar.2019.01204

Ejemplares similares

Notoginsenoside R1 Improves Cerebral Ischemia/Reperfusion Injury by Promoting Neurogenesis via the BDNF/Akt/CREB Pathway
por: Zhu, Ting, et al.
Publicado: (2021)

Ginkgolide B for Myocardial Ischemia/Reperfusion Injury: A Preclinical Systematic Review and Meta-Analysis
por: Zhu, Peng-Chong, et al.
Publicado: (2019)

Ligustrazine Exerts Cardioprotection in Animal Models of Myocardial Ischemia/Reperfusion Injury: Preclinical Evidence and Possible Mechanisms
por: Zheng, Qun, et al.
Publicado: (2018)

Pharmacological properties and mechanisms of Notoginsenoside R1 in ischemia-reperfusion injury
por: Zhu, Ting, et al.
Publicado: (2023)

Protective effects of notoginsenoside R1 on cerebral ischemia-reperfusion injury in rats
por: Zou, Shun, et al.
Publicado: (2017)

Cardioprotective effect of curcumin on myocardial ischemia/reperfusion injury: a meta-analysis of preclinical animal studies
por: Zeng, Yi-Fan, et al.
Publicado: (2023)

Danshensu for Myocardial Ischemic Injury: Preclinical Evidence and Novel Methodology of Quality Assessment Tool
por: Bao, Xiao-yi, et al.
Publicado: (2018)

Notoginsenoside R1 Ameliorates Cardiac Lipotoxicity Through AMPK Signaling Pathway
por: Tian, Xue, et al.
Publicado: (2022)

Notoginsenoside R1 Suppresses Inflammatory Signaling and Rescues Renal Ischemia-Reperfusion Injury in Experimental Rats
por: Fan, Chuming, et al.
Publicado: (2020)

Effect of tanshinone IIA for myocardial ischemia/reperfusion injury in animal model: preclinical evidence and possible mechanisms
por: Zhu, Peng-Chong, et al.
Publicado: (2023)

Astragaloside IV Exerts Cardioprotection in Animal Models of Viral Myocarditis: A Preclinical Systematic Review and Meta-Analysis
por: Zhuang, Zhuang, et al.
Publicado: (2019)

Sodium danshensu attenuates cerebral ischemia–reperfusion injury by targeting AKT1
por: Gao, Qing, et al.
Publicado: (2022)

Chick Embryo: A Preclinical Model for Understanding Ischemia-Reperfusion Mechanism
por: Fauzia, Eram, et al.
Publicado: (2018)

Notoginsenoside R1 (NG-R1) Promoted Lymphatic Drainage Function to Ameliorating Rheumatoid Arthritis in TNF-Tg Mice by Suppressing NF-κB Signaling Pathway
por: Jiao, Danli, et al.
Publicado: (2022)

Ginsenoside Rb1 for Myocardial Ischemia/Reperfusion Injury: Preclinical Evidence and Possible Mechanisms
por: Zheng, Qun, et al.
Publicado: (2017)

Notoginsenoside R1 Protects Against the Acrylamide-Induced Neurotoxicity via Upregulating Trx-1-Mediated ITGAV Expression: Involvement of Autophagy
por: Wang, Wenjun, et al.
Publicado: (2020)

Preclinical Evidence of Paeoniflorin Effectiveness for the Management of Cerebral Ischemia/Reperfusion Injury: A Systematic Review and Meta-Analysis
por: Wang, Anzhu, et al.
Publicado: (2022)

Puerarin: A protective drug against ischemia-reperfusion injury
por: Gao, Minglang, et al.
Publicado: (2022)

A Preclinical Systematic Review of Curcumin for Protecting the Kidney with Ischemia Reperfusion Injury
por: Wang, Zi-Hao, et al.
Publicado: (2020)

Cardioprotective effects of Notoginsenoside R1 against ischemia/reperfusion injuries by regulating oxidative stress- and endoplasmic reticulum stress- related signaling pathways
por: Yu, Yingli, et al.
Publicado: (2016)

Notoginsenoside R1 Regulates Ischemic Myocardial Lipid Metabolism by Activating the AKT/mTOR Signaling Pathway
por: Lei, Wei, et al.
Publicado: (2022)

Exploring the molecular mechanism of notoginsenoside R1 in sepsis-induced cardiomyopathy based on network pharmacology and experiments validation
por: Shao, Ruifei, et al.
Publicado: (2023)

Notoginsenoside R1 Reverses Abnormal Autophagy in Hippocampal Neurons of Mice With Sleep Deprivation Through Melatonin Receptor 1A
por: Cao, Yin, et al.
Publicado: (2021)

A Preclinical Systematic Review and Meta-Analysis of Astragaloside IV for Myocardial Ischemia/Reperfusion Injury
por: Zheng, Qun, et al.
Publicado: (2018)

The protective effect of vagus nerve stimulation against myocardial ischemia/reperfusion injury: pooled review from preclinical studies
por: Xu, Yu-Peng, et al.
Publicado: (2023)

Notoginsenoside R1 Protects Against Diabetic Cardiomyopathy Through Activating Estrogen Receptor α and Its Downstream Signaling
por: Zhang, Bin, et al.
Publicado: (2018)

Corrigendum: Notoginsenoside R1 Reverses Abnormal Autophagy in Hippocampal Neurons of Mice With Sleep Deprivation Through Melatonin Receptor 1A
por: Cao, Yin, et al.
Publicado: (2022)

Role of curcumin in ischemia and reperfusion injury
por: Bi, Minglei, et al.
Publicado: (2023)

Neuroprotective Effect of Astragaloside IV on Cerebral Ischemia/Reperfusion Injury Rats Through Sirt1/Mapt Pathway
por: Shi, Yi-Hua, et al.
Publicado: (2021)

Eugenol Attenuates Cerebral Ischemia-Reperfusion Injury by Enhancing Autophagy via AMPK-mTOR-P70S6K Pathway
por: Sun, Xiaowei, et al.
Publicado: (2020)

Phospholipase Cγ2 Signaling Cascade Contribute to the Antiplatelet Effect of Notoginsenoside Fc
por: Liu, Yingqiu, et al.
Publicado: (2018)

Metabolomics profiling to characterize cerebral ischemia-reperfusion injury in mice
por: Chen, Qiong, et al.
Publicado: (2023)

Geniposide Combined With Notoginsenoside R1 Attenuates Inflammation and Apoptosis in Atherosclerosis via the AMPK/mTOR/Nrf2 Signaling Pathway
por: Liu, Xiaoyu, et al.
Publicado: (2021)

Ginsenoside Rg1-Notoginsenoside R1-Protocatechuic Aldehyde Reduces Atherosclerosis and Attenuates Low-Shear Stress-Induced Vascular Endothelial Cell Dysfunction
por: Zhang, Lei, et al.
Publicado: (2021)

PPARγ in Ischemia-Reperfusion Injury: Overview of the Biology and Therapy
por: Huang, Ruizhen, et al.
Publicado: (2021)

Fasudil, a Rho-Kinase Inhibitor, Exerts Cardioprotective Function in Animal Models of Myocardial Ischemia/Reperfusion Injury: A Meta-Analysis and Review of Preclinical Evidence and Possible Mechanisms
por: Huang, Yue-yue, et al.
Publicado: (2018)

Fibroblast Growth Factors in the Management of Acute Kidney Injury Following Ischemia-Reperfusion
por: Deng, Lian-Cheng, et al.
Publicado: (2020)

Anti-inflammatory Effects of Traditional Chinese Medicines on Preclinical in vivo Models of Brain Ischemia-Reperfusion-Injury: Prospects for Neuroprotective Drug Discovery and Therapy
por: Peng, Tangming, et al.
Publicado: (2019)

Neuroprotective Effects and Hepatorenal Toxicity of Angong Niuhuang Wan Against Ischemia–Reperfusion Brain Injury in Rats
por: Tsoi, Bun, et al.
Publicado: (2019)

Protective Effects of HDL Against Ischemia/Reperfusion Injury
por: Gomaraschi, Monica, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_u92956nmhvmfgogfing6p471me